These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20180771)

  • 1. Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.
    Moutzouri E; Florentin M; Elisaf MS; Mikhailidis DP; Liberopoulos EN
    Curr Vasc Pharmacol; 2010 May; 8(3):344-62. PubMed ID: 20180771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct renin inhibition: focus on aliskiren.
    Pool JL
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl B):21-33. PubMed ID: 17970614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.
    Angeli F; Reboldi G; Mazzotta G; Poltronieri C; Garofoli M; Ramundo E; Biadetti A; Verdecchia P
    Curr Drug Saf; 2012 Feb; 7(1):76-85. PubMed ID: 22663961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
    Rashikh A; Ahmad SJ; Pillai KK; Najmi AK
    J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy.
    Sureshkumar KK
    Vasc Health Risk Manag; 2008; 4(6):1205-20. PubMed ID: 19337534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Vasiuk IuA; Sadulaeva IA; Iushchuk EN; Trofimenko OS; Chirkov MV; Fedoseeva VS; Kulikov KG
    Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliskiren: a review of its use in the management of hypertension.
    Frampton JE; Curran MP
    Drugs; 2007; 67(12):1767-92. PubMed ID: 17683174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren in the management of hypertension.
    Barrios V; Escobar C
    Am J Cardiovasc Drugs; 2010; 10(6):349-58. PubMed ID: 21090828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
    Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
    Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness.
    Sealey JE; Laragh JH
    Am J Hypertens; 2007 May; 20(5):587-97. PubMed ID: 17485026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M; Simioni N; Masiero A
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
    Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antihypertensive effectiveness and safety of dual RAAS blockade with aliskiren and valsartan.
    Chrysant SG
    Drugs Today (Barc); 2010 Mar; 46(3):151-62. PubMed ID: 20467589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.